Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (41-50 of 293) with videos related to

Pageof 30
Sort By:
NPJ Breast Cancer|January 14, 2022
The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysisDella Makower, Jiyue Qin, Juan Lin, et al.
Expert Opinion on Pharmacotherapy|April 18, 2015
Therapies for triple negative breast cancerEleni Andreopoulou, Sarah J Schweber, Joseph A Sparano, et al.
Radiology|October 1, 1996
Stereotactic core needle biopsy of multiple sites in the breast: efficacy and effect on patient careR Rosenblatt, S A Fineberg, J A Sparano, et al.
Medical Oncology (Northwood, London, England)|April 1, 2003
Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphomaMuhammad R Abbasi, Joseph A Sparano, Catherine Sarta, et al.
Journal of Racial and Ethnic Health Disparities|December 23, 2016
Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer PopulationGeoffrey C Kabat, Mindy Ginsberg, Joseph A Sparano, et al.
Cancer|February 15, 1991
Complete remission in refractory anaplastic adult Wilms' tumor treated with cisplatin and etoposideJ A Sparano, J B Beckwith, S Mitsudo, et al.
Journal of Surgical Oncology|June 12, 1998
Tenascin pattern of expression and established prognostic factors in invasive breast carcinomaB F Iskaros, X Hu, J A Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapyJ A Sparano, P H Wiernik, A Leaf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical TrialsJoseph A Sparano, Robert Gray, Bruce Giantonio, et al.
Oncoimmunology|September 26, 2015
HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 familiesMurali Janakiram, Jordan M Chinai, Aimin Zhao, et al.
Pageof 30

Showing results (41-50 of 293) with videos related to

Sort By:
Pageof 30
NPJ Breast Cancer|January 14, 2022
The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysisDella Makower, Jiyue Qin, Juan Lin, et al.
Expert Opinion on Pharmacotherapy|April 18, 2015
Therapies for triple negative breast cancerEleni Andreopoulou, Sarah J Schweber, Joseph A Sparano, et al.
Radiology|October 1, 1996
Stereotactic core needle biopsy of multiple sites in the breast: efficacy and effect on patient careR Rosenblatt, S A Fineberg, J A Sparano, et al.
Medical Oncology (Northwood, London, England)|April 1, 2003
Phase I trial of fludarabine and paclitaxel in non-Hodgkin's lymphomaMuhammad R Abbasi, Joseph A Sparano, Catherine Sarta, et al.
Journal of Racial and Ethnic Health Disparities|December 23, 2016
Risk of Recurrence and Mortality in a Multi-Ethnic Breast Cancer PopulationGeoffrey C Kabat, Mindy Ginsberg, Joseph A Sparano, et al.
Cancer|February 15, 1991
Complete remission in refractory anaplastic adult Wilms' tumor treated with cisplatin and etoposideJ A Sparano, J B Beckwith, S Mitsudo, et al.
Journal of Surgical Oncology|June 12, 1998
Tenascin pattern of expression and established prognostic factors in invasive breast carcinomaB F Iskaros, X Hu, J A Sparano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Infusional cyclophosphamide, doxorubicin, and etoposide in relapsed and resistant non-Hodgkin's lymphoma: evidence for a schedule-dependent effect favoring infusional administration of chemotherapyJ A Sparano, P H Wiernik, A Leaf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical TrialsJoseph A Sparano, Robert Gray, Bruce Giantonio, et al.
Oncoimmunology|September 26, 2015
HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 familiesMurali Janakiram, Jordan M Chinai, Aimin Zhao, et al.
Pageof 30